Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor

• 收藏
• 分享

专利权人:

Acerta Pharma B.V.

发明人:

Wayne Rothbaum,Brian Lannutti,Allard Kaptein

申请号：

US16365085

公开号：

US20190374539A1

申请日:

2019.03.26

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Therapeutic combinations of a MEK inhibitor and a Bruton's tyrosine kinase (BTK) inhibitor are described. In some embodiments, the invention provides pharmaceutical compositions comprising combinations of a MEK inhibitor and a BTK inhibitor and methods of using the pharmaceutical compositions for treating a disease, in particular a cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/